Treating Hodgkin and non-Hodgkin lymphoma with proton therapy
Proton therapy is different from photon-based radiotherapy. Because of their unique physical properties, protons have no ‘exit’ dose and very little ‘entrance’...
Proton therapy is different from photon-based radiotherapy. Because of their unique physical properties, protons have no ‘exit’ dose and very little ‘entrance’...
During ISOP 2022, Hans Langendijk presented the Model-based Approach. Watch the webinar above.
During ISOP 2022, Alonso Gutierrez presented "Single vs Multi Room – What’s Best for the Future?". Watch the webinar above.
During ISOP 2022, Mark Pankuch presented How to Manage Organ Motion. Watch the webinar above.
IBA User Meeting 2022
Session: Clinical trends
1. Does proton beam radiotherapy have a role in metastatic disease?
2. Proton arc therapy shows the...
IBA Proteus User Meeting 2022
Session: Clinical achievements: clinical evidence and PT acceptance
IBA User Meeting 2022
Session: Show & Tell: clinical cases
IBA User Meeting 2022
Session: IBA Roadmap and product strategy